Call for assessing treatment-induced gonadotoxicity of platinum-based chemotherapy in early breast cancer

Breast Cancer Res Treat. 2020 Aug;183(1):239-240. doi: 10.1007/s10549-020-05767-3. Epub 2020 Jun 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carboplatin / administration & dosage
  • Carboplatin / adverse effects*
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects
  • Docetaxel / administration & dosage
  • Docetaxel / adverse effects
  • Epirubicin / administration & dosage
  • Epirubicin / adverse effects
  • Female
  • Humans
  • Ovary / drug effects*
  • Paclitaxel / administration & dosage
  • Paclitaxel / adverse effects
  • Primary Ovarian Insufficiency / chemically induced*
  • Primary Ovarian Insufficiency / pathology
  • Randomized Controlled Trials as Topic
  • Treatment Outcome
  • Triple Negative Breast Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Docetaxel
  • Epirubicin
  • Cyclophosphamide
  • Carboplatin
  • Paclitaxel